HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Cipolla Selected Research

Bronchiectasis

5/2023Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
10/2020Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies.
9/2013Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Cipolla Research Topics

Disease

9Infections
08/2023 - 08/2013
5Pulmonary Arterial Hypertension
03/2023 - 01/2021
5Cystic Fibrosis (Mucoviscidosis)
01/2022 - 09/2013
3Bronchiectasis
05/2023 - 09/2013
2Hypoxia (Hypoxemia)
10/2022 - 02/2022
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2022 - 12/2012
2Asthma (Bronchial Asthma)
01/2022 - 01/2020
2Neoplasms (Cancer)
01/2020 - 11/2010
2Lung Diseases (Lung Disease)
02/2018 - 11/2010
1Pulmonary Hypertension
03/2023
1Interstitial Lung Diseases (Interstitial Lung Disease)
03/2023
1Vascular Remodeling
02/2022
1Chronic Obstructive Pulmonary Disease (COPD)
01/2022
1Cough
01/2021
1COVID-19
01/2020
1Dehydration (Water Stress)
01/2019
1Q Fever (Fever, Q)
03/2016
1Mycoses (Diseases, Fungus)
03/2016
1Tuberculosis (Tuberculoses)
03/2016
1Tularemia
03/2016
1Plague (Bubonic Plague)
03/2016
1Emphysema
11/2010
1Heart Diseases (Heart Disease)
11/2010
1Thymoma (Thymic Carcinoma)
02/2004

Drug/Important Bio-Agent (IBA)

8Ciprofloxacin (Cipro)FDA LinkGeneric
10/2020 - 12/2012
6Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 09/2013
5treprostinilFDA Link
03/2023 - 01/2021
3LipoglycopeptidesIBA
08/2023 - 01/2021
3PowdersIBA
08/2023 - 01/2021
3ProdrugsIBA
03/2023 - 01/2021
3AerosolsIBA
01/2022 - 11/2010
2Vasodilator Agents (Vasodilators)IBA
10/2022 - 01/2021
2SuspensionsIBA
02/2022 - 01/2021
2Mannitol (Osmitrol)FDA LinkGeneric
01/2022 - 02/2018
1Serine Proteases (Serine Protease)IBA
05/2023
1brensocatibIBA
05/2023
1Sildenafil Citrate (Viagra)FDA Link
10/2022
1selexipagIBA
10/2022
1Phosphodiesterase 5 InhibitorsIBA
10/2022
1Semaxinib (SU5416)IBA
02/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1Cholinergic ReceptorsIBA
01/2022
1Surface-Active Agents (Surfactants)IBA
01/2022
1Muscarinic AgonistsIBA
01/2022
1Prostaglandins IIBA
01/2022
1Bradykinin B2 Receptor AntagonistsIBA
01/2021
1Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2021
1ProstaglandinsIBA
01/2021
1Cyclooxygenase InhibitorsIBA
01/2021
1TachykininsIBA
01/2021
1VancomycinFDA LinkGeneric
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2020
1Liposomes (Liposome)IBA
01/2020
1Biological Warfare AgentsIBA
03/2016
1AztreonamFDA LinkGeneric
09/2013
1Tobramycin (Nebcin)FDA LinkGeneric
09/2013
1Amikacin (A.M.K)FDA LinkGeneric
08/2013

Therapy/Procedure

2Therapeutics
02/2018 - 02/2004
1Respiratory Therapy (Therapy, Respiratory)
08/2023
1Nebulizers and Vaporizers (Inhaler)
11/2010
1Tobacco Use Cessation Devices
11/2010